Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Get email alerts on the Committee Hearing Roundup topic
No spam. Unsubscribe anytime.
House Health and Human Services holds six bills for further study after Thursday hearing
Summary
The House Health and Human Services Committee voted to hold six bills for further study and heard testimony on measures including a rare disease advisory council, requiring AEDs at golf courses, cosmetics labeling, harm reduction center extension, and a secondhand marijuana smoke proposal.
Chairwoman Donovan convened the House Committee on Health and Human Services on Feb. 6, 2025, and members voted to hold six bills for further study after a procedural motion. Representative Place was recorded as opposing the motion.
The committee then heard testimony on several bills scheduled for review: House Bill 5,023 (establish a Rare Disease Advisory Council), H. 5,083 (require automated external defibrillators at golf courses), H. 5,117 (cosmetic ingredients labeling amendment), H. 5,171 (extend and codify the harm reduction center pilot), H. 5,027 (address secondhand marijuana smoke), and H. 5,045 (extend reporting date for a study commission on Title IV funding). Several bills drew extended public testimony and stakeholder presentations; others drew little or no oral testimony.
Why it matters: The committee’s procedural hold gives members time to review written and verbal testimony and signals no committee-level decision on the merits. The hearing included extensive public-health testimony on rare diseases and overdose prevention and a high-profile personal plea to require AEDs at golf courses.
Votes at a glance
- Motion to hold bills for further study (list included H. 5,023; H. 5,027; H. 5,045; H. 5,083; H. 5,117; H. 5,171): Passed by voice vote; Representative Place recorded as opposed. (Motion text: “to hold the following bills for further study.”)
What’s next: Each bill remains under committee consideration. Sponsors and advocates may file amendments or return with additional information before the committee advances any measure.
